DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)]

European Journal of Biochemistry

Volumn 254, Issue 3, 1998, Pages 547-557

  Žákovská, Alena ^a   Nováková, Olga ^a   Balcarová, Zdeňka ^a   Bierbach, Ulrich ^b   Farrell, Nicholas ^b   Brabec, Viktor ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antitumor activity; Conformation; DNA; Platinum drug; Quinoline

Indexed keywords

CISPLATIN; CISPLATIN DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CONFORMATIONAL TRANSITION; CROSS LINKING; DNA CONFORMATION; DRUG CONFORMATION; DRUG DNA INTERACTION; NONHUMAN; PRIORITY JOURNAL; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CATTLE; DNA; DNA ADDUCTS; ETHIDIUM; FLUORESCENT DYES; MOLECULAR SEQUENCE DATA; ORGANOMETALLIC COMPOUNDS; ORGANOPLATINUM COMPOUNDS; THIOUREA;

EID: 0032525936     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2540547.x     Document Type: Article

References (52)

1. Lepre, C. A. & Lippard, S. J. (1990) Interaction of platinum antitumor compounds with DNA, Nucleic Acids Mol. Biol. 4, 9-38.
2. Reedijk, J. (1992) The relevance of hydrogen bonding in the mechanism of action of platinum antitumor compounds, Inorg. Chim. Acta 198, 873-881.
3. Farrell, N. (1996) Current status of structure/activity relationships of platinum anticancer drugs: Activation of the trans geometry, in Metal ions in biological systems (Sigel, A. & Sigel, H., eds) pp. 603-639, Marcel Dekker, New York.
4. Farrell, N., Kelland, L. R., Roberts, J. D. & Van Beusichem, M. (1992) Activation of the trans geometry in platinum antitumor complexes: A survey of the cytotoxicity of trans complexes containing planar ligands in murine-L1210 and human tumor panels and studies on their mechanism of action, Cancer Res. 52, 5065-5072.
5. Coluccia, M., Nassii, F., Loseto, F., Boccarelli, A., Marigió, M. A., Giordano, D., Intini, F. P., Caputo, P. & Natile, G. (1993) A transplatinum complex showing higher antitumor activity than the cis congeners, J. Med. Chem. 36, 510-512.
6. Coluccia, M., Boccarelli, A., Mariggio, M. A., Cardellicchio, N., Caputo, P., Intini, F. P. & Natile, G. (1995) Platinum(II) complexes containing iminoethers: A trans platinum antitumour agent, Chem.-Biol. Interact. 98, 251-266.
7. 2], Nucleic Acids Res. 24, 336-341.
8. 2], Mol. Pharmacol. 52, 354-361.
9. 3, pyridine), Biochemistry 32, 9632-9638.
10. Marples, B., Adomat, H., Billings, P. C., Farrell, N. P., Koch, C. J. & Skov, K. A. (1994) Recognition of platinum-induced DNA damage by nuclear proteins: Screening for mechanisms, Anti-Cancer Drug Design 9, 389-399.
11. 3)quinoline], Anti-Cancer Drug Design 9, 103-117.
12. Van Beusichem, M. & Farrell, N. (1992) Activation of trans geometry in platinum antitumor complexes. Synthesis, characterization, and biological activity of complexes with the planar ligands pyridine, N-methylimidazole, thiazole, and quinoline. Crystal and molecular structure of trans-dichlorobis (thiazole)platinum(II), Inorg. Chem. 31, 634-639.
13. Brabec, V. & Puleček, E. (1970) The influence of salts and pH on polarographic currents produced by denatured DNA, Biophys. 27, 145-150.
14. Brabec, V. & Paleček, E. (1976) Interaction of nucleic acids with electrically charged surfaces. II. Conformational changes in double-helical polynucleotides, Biophys. Chem. 4, 76-92.
15. Kim, S. D., Vrána, O., Kleinwächter, V., Niki, K. & Brabec, V. (1990) Polarographic determination of subnanogram quantities of tree platinum in reaction mixture with DNA, Anal. Lett. 23, 1505-1518.
16. Lemaire, M. A., Schwartz, A., Rahmouni, A. R. & Leng, M. (1991) Interstrand cross-links are prefentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum(II) and DNA, Proc. Natl Acad. Sci. USA 88, 1982-1985.
17. Brabec, V. & Leng, M. (1993) DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues, Proc. Natl Acad. Sci. USA 90, 5345-5349.
18. Butour, J. L. & Macquet, J. P. (1977) Differentiation of DNA-platinum complexes by fluorescence. The use of an intercalating dye as a probe, Eur. J. Biochem. 78, 455-463.
19. Topal, M. D. & Fresco, J. R. (1980) Fluorescence of terbium ionnucleic acid complexes: A sensitive specific probe for unpaired residues in nucleic acids, Biochemistry 19, 5531-5537.
20. Balcarová, Z. & Brabec, V. (1989) Reinterpretation of fluorescence of terbium ion-DNA complexes, Biophys. Chem. 33, 55-61.
21. Keck, M. V. & Lippard, S. J. (1992) Unwinding of supereoiled DNA by platinum ethidium and related complexes, J. Am. Chem. Soc. 114, 3386-3390.
22. Lippard, S. J., Ushay, H. M., Merkel, C. M. & Poirier, M. C. (1983) Use of antibodies to probe the stereochemistry of antitumor platinum drug binding to deoxyribonucleic acid, Biochemistry 22, 5165-5168.
23. Brabec, V., Vrána, O., Kiseleva, V. I. & Poverenny, A. M. (1991) Polyclonal antibodies elicited against trans-diamminedichloroplatinum(II)-modified DNA and their application in nonradioactive hybridization experiments, Eur. J. Biochem. 201, 723-730.
24. Vrána, O., Kiseleva, V. I., Poverenny, A. M. & Brabec, V. (1992) Conversion of DNA adducts of antitumour cis-diamminedichloroplatinum(II) - immunochemical analysis, Eur. J. Pharmacol. 226, 5-13.
25. Weiner, S. J., Kollman, P. A., Nguyen, D. T. & Case, D. A. (1986) An all atom force field for simulations of proteins and nucleic acids, J. Comput. Chem. 7, 230-252.
26. Bierbach, U. & Farrell, N. (1997) Modulation of nucleotide binding of trans platinum(II) complexes by planar ligands. A combined proton NMR and molecular mechanics study, Inorg. Chem. 36, 3657-3665.
27. Reference deleted.
28. Brabec, V., Boudný, V. & Balcarová, Z. (1994) Monofunctional adducts of platinum(II) produce in DNA a sequence-dependent local denaturation, Biochemistry 32, 1316-1322.
29. Nováková, O., Vrána, O., Kiseleva, V. I. & Brabec, V. (1995) DNA interactions of antitumor plutinum(IV) complexes, Eur. J. Biochem. 228, 616-624.
30. Fichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M. & Reedijk, J. (1985) Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: Formation, identification, and quantitation, Biochemistry 24, 707-713.
31. Eastman, A. (1987) The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes, Pharmacol. Ther. 34, 155-166.
32. Johnson, N. P., Butour, J.-L., Villani, G., Wimmer, F. L., Defais, M., Pierson, V. & Brabec, V. (1989) Metal antitumor compounds: The mechanism of action of platinum complexes, Prog. Clin. Biochem. Med. 10, 1-24.
33. Bancroft, D. P., Lepre, C. A. & Lippard, S. J. (1990) Pt-195 NMR kinetic and mechanistic studies of cis-diamminedichloroplatinum and trans-diamminedichloroplatinum(II) binding to DNA, J. Am. Chem. Soc. 112, 6860-6871.
34. Brabec, V., Kleinwächter, V., Butour, J. L. & Johnson, N. P. (1990) Biophysical studies of the modification of DNA by antitumour platinum coordination complexes, Biophys. Chem. 35, 129-141.
35. Eastman, A. & Barry, M. A. (1987) Interaction of trans-diamminedichloroplatinum(II) with DNA: Formation of monofunctional adducts and their reaction with glutathione, Biochemistry 26, 3303-3307.
36. 2], Eur. J. Biochem. 202, 975-980.
37. Bellon, S. F., Coleman, J. H. & Lippard, S. J. (1991) DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II), Biochemistry 30, 8026-8035.
38. Sundquist, W. I., Bancroft, D. P. & Lippard, S. J. (1990) Synthesis, characterization, and biological activity of cis-diammineplatinum(II) complexes of the DNA intercalators 9-aminoacridine and chloroquine, J. Am. Chem. Soc. 112, 1590-1596.
39. Farrell, N., Qu, Y., Feng, L. & Vanhouten, B. (1990) Comparison of chemical reactivity, cytotoxicity, interstrand cross-linking and DNA sequence specificity of bis(platinum) complexes containing monodentate or bidentate coordination spheres with their monomeric analogues, Biochemistry 29, 9522-9531.
40. Žaludová, R., Kleinwächter, V. & Brabec, V. (1996) The effect of ionic strength on melting of DNA modified by platinum(II) complexes, Biophys. Chem. 60, 135-142.
41. Arquilla, M., Thompson, L. M., Pearlman, L. F. & Simpkins, H. (1983) Effect of platinum antitumor agents on DNA and RNA investigated by terbium fluorescence, Cancer Res. 43, 1211-1216.
42. Sundquist, W. I., Lippard, S. J. & Stollar, B. D. (1987) Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II), Proc. Natl Acad. Sci. USA 84, 8225-8229.
43. Hollis, L. S., Sundquist, W. I., Burstyn, J. N., Heiger-Bernays, W. J., Bellon, S. F., Ahmed, K. J., Amundsen, A. R., Stern, E. W. & Lippard, S. J. (1991) Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents, Cancer Res. 51, 1866-1875.
44. Vrána, O., Boudný, V. & Brabec, V. (1996) Superhelical torsion controls DNA interstrand cross-linking by antitumor cis-diamminedichloroplatinum(II), Nucleic Acids Res. 24, 3918-3925.
45. Saenger, W. (1984) Principles of nucleic acid structure (Cantor, C. R., ed.) Springer-Verlag, New York.
46. Admiraal, G., van der Veer, J. L., de Graaff, R. A. G., den Hartog, J. H. J. & Reedijk, J. (1987) Intrastrand bis(guanine) chelaton of d(CpGpG) to cis-platinum: An X-ray single crystal structure analysis, J. Am. Chem. Soc. 109, 592-594.
47. 2{d(pGpG)}], the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA, J. Am. Chem. Soc. 110, 7368-7380.
48. Takahara, P. M., Frederick, C. A. & Lippard, S. J. (1996) Crystal structure of the anticancer drug cisplatin bound to duplex DNA, J. Am. Chem. Soc. 118, 12309-12321.
49. Herman, F., Kozelka, J., Stoven, V., Guittet, E., Girault, J. P., Huynh-Dinh, T., Igolen, J., Lallemand, J. Y. & Chottard, J. C. (1990) A d(GpG)-platinated decanucleotide duplex is kinked. An extended NMR and molecular mechanics study, Eur. J. Biochem. 194, 119-133.
50. Dickerson, R. E., Bansal, M., Calladine, C. R., Diekmann, S., Hunter, W. N., Kennard, O., Lavery, R., Nelson, H. C., Olson, W. K., Saenger, W., Shakked, Z., Sklenar, H., Soumpasis, D. M., Tung, C.-S., Wang, A. H. C. & Zhurkin, V. B. (1989) Definitions and nomenclature of nucleic acid structure parameters, EMBO J. 8, 1-4.
51. Zamble, D. B., Mu, D., Reardon, J. T., Sancar, A. & Lippard, S. J. (1996) Repair of cisplatin-DNA adducts by the mammalian excision nuclease, Biochemistry 35, 10004-10013.
52. Boudvillain, M., Dalbies, R., Aussourd, C. & Leng, M. (1995) Intrastrand cross-links are not formed in the reaction between transplatin and native DNA: Relation with the clinical inefficiency of transplatin, Nucleic Acids Res. 23, 2381-2388.